TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/20/25 19:29 | 8/18/25 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Niklason Laura E | NC | DO | P,CEO,Di | S.m | -3,733 | 1.67 | 0 | -2,241 | -62 | 1,392 | I | ||||||||||||||
11/20/24 19:06 | 11/18/24 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Niklason Laura E | NC | DO | P,CEO,Di | S.m | -6,607 | 4.40 | 0 | -1,500 | -29 | 3,631 | I | ||||||||||||||
9/11/24 17:50 | 9/9/24 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Niklason Laura E | NC | DO | P,CEO,Di | S.m | -2,365 | 5.30 | 0 | -446 | -8 | 5,131 | I | ||||||||||||||
8/29/24 18:48 | 8/27/24 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Niklason Laura E | NC | DO | P,CEO,Di | S.m | -5,724 | 6.49 | 0 | -882 | -14 | 5,576 | I | ||||||||||||||
6/13/24 16:48 | 6/11/24 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Niklason Laura E | NC | DO | P,CEO,Di | S.m | -4,520 | 7.17 | 0 | -630 | -9 | 6,458 | I | ||||||||||||||
6/4/24 18:57 | 5/31/24 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Niklason Laura E | NC | DO | P,CEO,Di | S.m | -7,832 | 7.82 | 0 | -1,002 | -12 | 7,086 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |